Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients

Yonsei Medical Journal

Volumn 46, Issue 1, 2005, Pages 78-85

  Choi, Eui Young ^a   Kwon, Hyuck Moon ^a,d   Ahn, Chul Woo ^a   Lee, Geun Taek ^b   Joung, Boyoung ^a   Hong, Bum Kee ^a   Yoon, Young Won ^a   Kim, Dongsoo ^a   Byun, Ki Hyun ^c   Kang, Tae Soo ^a   Yoon, Se Jung ^a   Kwon, Sung Woo ^a   Lee, Sung Ju ^a   Park, Jong Kwan ^a   Kim, Hyun Seung ^a  

^a Yonsei University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Catholic Kwandong University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Angioplasty; Coronary artery disease; Diabetes mellitus; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PREDICTION; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 20144385742     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.1.78     Document Type: Article

References (16)

1. Belle EV, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary arteries. Circulation 1997;96: 1454-60.
2. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30.
3. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003;93:1159-69.
4. Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, et al. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003;107:2238-43.
5. Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, Dansky HM. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 2003;23:2027-33.
6. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003;111: 959-72.
7. Tanaka S, Avigad G, Brodsky B, Eikenberry EF. Glycation induces expansion of the molecular packing of collagen. J Mol Biol 1988;203:495-505.
8. Haitoglou CS, Tsilbary EC, Brownlee M, Charonis AS. Altered cellular interactions between endothelial cells and nonenzymatically glycosylated laminin/type IV collagen. J Biol Chem 1992;267:12404-7.
9. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul V, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty multivessel coronary disease: implications for patient selection. Circulation 1990;82:1193-202.
10. Wrobel K, Wrobel K, Garay-Sevilla ME, Nava LE, Malacara JM. Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 1997;43: 1563-9.
11. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8.
12. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, et al. Diabetes control and complications trial; Epidemiology of diabetes interventions and complications research group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes. N Engl J Med 2003;348:2294-303.
13. West NEJ, Ruygrok PN, Disco CMC, Webster MWI, Lindeboom WK, O'Neill WW, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 2004;109:867-73.
14. Brownlee M, Cerami A, Vlassara H. Advanced glycation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
15. Niwa T. 3-Deoxyglucosone metabolism, analysis, biological activity, and clinical implication. J Chromatogr B Biomed Sci Appl 1999;731:23-36.
16. Hasuike Y, Nakanishi T, Otaki Y, Nanami M, Tanimoto T, Taniguchi N, et al. Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes. Am J Kidney Dis 2002;40:464-71.